Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.21
-0.07 (-0.85%)
Nov 4, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$13.75
Upside
+67.48%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +82.70% | Sep 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +82.70% | Aug 6, 2024 |
TD Cowen | TD Cowen | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +9.62% | Aug 6, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $15 → $10 | Buy → Hold | Downgrades | $15 → $10 | +21.80% | Aug 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +143.61% | May 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +143.61% | May 14, 2024 |
BTIG | BTIG | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +155.79% | Apr 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +143.61% | Aug 8, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | +143.61% | May 9, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +131.43% | Feb 28, 2023 |
SVB Leerink | SVB Leerink | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +70.52% | Nov 17, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $19 | Strong Buy | Maintains | $12 → $19 | +131.43% | Nov 8, 2022 |
Morgan Stanley | Morgan Stanley | Sell Maintains $11 → $10 | Sell | Maintains | $11 → $10 | +21.80% | Jul 25, 2022 |
SVB Leerink | SVB Leerink | Buy Initiates $12 | Buy | Initiates | $12 | +46.16% | May 23, 2022 |
Morgan Stanley | Morgan Stanley | Sell Maintains $10 → $11 | Sell | Maintains | $10 → $11 | +33.98% | Mar 2, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +46.16% | Feb 24, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.